Core Viewpoint - The company, Boan Biotechnology, announced a placement agreement to sell 48 million shares, representing approximately 8.36% of its issued shares as of the announcement date [1] Group 1: Placement Details - The placement price is set at HKD 16.42 per share, which reflects an approximate discount of 8.78% compared to the closing price on the last trading day [1] - The expected net proceeds from the placement are approximately HKD 780 million [1] Group 2: Use of Proceeds - About 50% of the proceeds will be allocated for research and development, clinical trials, registration documents, and manufacturing of innovative candidate products [1] - Approximately 20% will be used for the commercialization of already listed and upcoming products [1] - Around 30% will be utilized to supplement the company's working capital and for general corporate purposes [1]
博安生物：拟配售4800万股，净筹约7.8亿港元